Skip to main content

UBS Group AG

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in SABS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,426,924
+$1,248,360 QoQ
Shares Held
372,445
+633.0% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 86 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SABS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. SABS ranks #241 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SABS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 SABSW 6,567
2026-06-30 $1,426,924 365,878
2026-03-31 SABSW 4,186
2026-03-31 $178,564 46,623
2025-12-31 SABSW 6,186
2025-12-31 $27,668 7,398
2025-09-30 SABSW 23,414
2025-09-30 $26,574 13,221
2025-06-30 $18,704 10,658
2025-03-31 $105 78
2024-12-31 SABSW 1,633
2024-12-31 $4,108 1,083
2024-06-30 SABSW 56
2023-12-31 SABSW 29,080
2023-12-31 $344 500
2023-06-30 SABSW 100
2023-03-31 $2,938 6,679
2022-12-31 $4,086 6,927
2022-09-30 SABSW 5,606
2022-09-30 $1,054 1,504
2022-06-30 $1,450 1,000
2022-03-31 $5,290 1,407
2021-12-31 SABSW 2,888
2021-12-31 $46,492 5,953
2021-06-30 BCYP 1,483
2021-03-31 BCYP 866